CGB7

gene
On this page

Also known as CG-beta-a

Summary

CGB7 (chorionic gonadotropin subunit beta 7, HGNC:16451) is a protein-coding gene on chromosome 19q13.33, encoding Choriogonadotropin subunit beta 7 (P0DN87). Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated.

This gene is a member of the glycoprotein hormone beta chain family and encodes the beta 7 subunit of chorionic gonadotropin (CG). Glycoprotein hormones are heterodimers consisting of a common alpha subunit and an unique beta subunit which confers biological specificity. CG is produced by the trophoblastic cells of the placenta and stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy. The beta subunit of CG is encoded by 6 genes which are arranged in tandem and inverted pairs on chromosome 19q13.3 and contiguous with the luteinizing hormone beta subunit gene.

Source: NCBI Gene 94027 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 48 total
  • MANE Select transcript: NM_001385261

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16451
Approved symbolCGB7
Namechorionic gonadotropin subunit beta 7
Location19q13.33
Locus typegene with protein product
StatusApproved
AliasesCG-beta-a
Ensembl geneENSG00000196337
Ensembl biotypeprotein_coding
OMIM608826
Entrez94027

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 8 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000596965, ENST00000597853, ENST00000598442, ENST00000684222, ENST00000880970, ENST00000880971, ENST00000929460, ENST00000929461, ENST00000929462

RefSeq mRNA: 2 — MANE Select: NM_001385261 NM_001385261, NM_033142

CCDS: CCDS33071

Canonical transcript exons

ENST00000684222 — 5 exons

ExonStartEnd
ENSE000022082054905536149056595
ENSE000025166854905484149055008
ENSE000037944704905712149057248
ENSE000039174094905427449054605
ENSE000039197914905746249057749

Expression profiles

Bgee: expression breadth broad, 82 present calls, max score 67.74.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1714 / max 12.0524, expressed in 76 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1819840.171476

Top tissues by expression

112 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lower esophagus mucosaUBERON:003583467.74gold quality
skin of abdomenUBERON:000141666.49gold quality
zone of skinUBERON:000001466.04gold quality
skin of legUBERON:000151165.94gold quality
olfactory segment of nasal mucosaUBERON:000538664.58gold quality
esophagus mucosaUBERON:000246963.65gold quality
stromal cell of endometriumCL:000225563.27gold quality
hindlimb stylopod muscleUBERON:000425263.04gold quality
skeletal muscle tissueUBERON:000113462.33gold quality
gastrocnemiusUBERON:000138861.30gold quality
muscle of legUBERON:000138361.18gold quality
prostate glandUBERON:000236759.95gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099157.77gold quality
vaginaUBERON:000099657.74gold quality
right uterine tubeUBERON:000130256.50gold quality
muscle tissueUBERON:000238556.43gold quality
saliva-secreting glandUBERON:000104453.27gold quality
minor salivary glandUBERON:000183053.08gold quality
placentaUBERON:000198752.45gold quality
esophagusUBERON:000104350.27gold quality
pituitary glandUBERON:000000749.30gold quality
right lungUBERON:000216748.97gold quality
duodenumUBERON:000211447.59silver quality
uterine cervixUBERON:000000247.24gold quality
thoracic mammary glandUBERON:000520046.97gold quality
ectocervixUBERON:001224946.58gold quality
urinary bladderUBERON:000125546.40gold quality
adenohypophysisUBERON:000219645.24gold quality
upper lobe of left lungUBERON:000895245.24gold quality
left uterine tubeUBERON:000130345.15gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-MTAB-8060yes3948.62
E-HCAD-5yes36.41
E-ANND-3no0.97

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): TP53

Literature-anchored findings (GeneRIF, showing 2)

  • Expression of the CGB7 gene is upregulated upon p53 induction in human HFF, HCT116 and DLD1 cells as well as in cell preparations enriched in human primary first-trimester trophoblasts. (PMID:22032922)
  • N- and O-glycosylation patterns and functional testing of CGB7 versus CGB3/5/8 variants of the human chorionic gonadotropin (hCG) beta subunit. (PMID:32767150)

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
drosophila_melanogasterGpb5FBGN0063368

Paralogs (9): CGB2 (ENSG00000104818), LHB (ENSG00000104826), CGB3 (ENSG00000104827), FSHB (ENSG00000131808), TSHB (ENSG00000134200), GPHB5 (ENSG00000179600), CGB5 (ENSG00000189052), CGB8 (ENSG00000213030), CGB1 (ENSG00000267631)

Protein

Protein identifiers

Choriogonadotropin subunit beta 7P0DN87 (reviewed: P0DN87)

All UniProt accessions (2): A0A0F7RQF0, P0DN87

UniProt curated annotations — full annotation on UniProt →

Function. Beta subunit of the human chorionic gonadotropin (hCG). hCG is a complex glycoprotein composed of two glycosylated subunits alpha and beta which are non-covalently associated. The alpha subunit is identical to those in the pituitary gonadotropin hormones (LH, FSH and TSH). The beta subunits are distinct in each of the hormones and confer receptor and biological specificity. Has an essential role for pregnancy and maternal adaptation. Stimulates the ovaries to synthesize the steroids that are essential for the maintenance of pregnancy.

Subunit / interactions. Heterodimer of a common alpha chain identical in LH, FSH, TSH and HCG and a unique beta chain distinct in each of the hormones and confers receptor and biological specificity.

Subcellular location. Secreted.

Tissue specificity. High expression in the placenta throughout pregnancy.

Miscellaneous. Encoded by a cluster of genes that have evolved by duplication from LHB. HCG-beta is encoded by six non-allelic genes (CGB) clustered on chromosome 19q13.3 and named CGB1, CGB2, CGB3, CGB5, CGB7 and CGB8. Two specific hCGb proteins that differ by three amino acids in positions 2,4 and 117 have been described: type 1 (CGB7) and type 2 (CGB3, CGB5, CGB8). The CGB gene first arose in the common ancestor of the anthropoid primates.

Similarity. Belongs to the glycoprotein hormones subunit beta family.

RefSeq proteins (2): NP_001372190, NP_149133 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001545Gonadotropin_bsuFamily
IPR006208Glyco_hormone_CNDomain
IPR018245Gonadotropin_bsu_CSConserved_site
IPR029034Cystine-knot_cytokineHomologous_superfamily

Pfam: PF00007

UniProt features (16 total): disulfide bond 6, glycosylation site 6, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0DN87-F178.700.46

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (6): 29–77, 43–92, 46–130, 54–108, 58–110, 113–120

Glycosylation sites (6): 33, 50, 141, 147, 152, 158

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 25 (showing top): BENPORATH_ES_WITH_H3K27ME3, GOBP_CELL_CELL_SIGNALING, GGARNTKYCCA_UNKNOWN, GOBP_FEMALE_GAMETE_GENERATION, GOMF_SIGNALING_RECEPTOR_BINDING, GOMF_HORMONE_ACTIVITY, SMAD4_Q6, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, EGR_Q6, SKIL_TARGET_GENES, ZNF563_TARGET_GENES, DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS, DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY

GO Biological Process (5): apoptotic process (GO:0006915), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), cell-cell signaling (GO:0007267), female gamete generation (GO:0007292)

GO Molecular Function (2): hormone activity (GO:0005179), signaling receptor binding (GO:0005102)

GO Cellular Component (3): obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell communication2
signaling2
cellular anatomical structure2
programmed cell death1
apoptotic signaling pathway1
execution phase of apoptosis1
cellular process1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
gamete generation1
receptor ligand activity1
protein binding1
intracellular anatomical structure1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A6NKQ9, B1AWI6, G7PWZ3, I6M4H4, O09108, O46482, O46483, O46641, O77805, O77835, P01229, P01230, P01231, P01232, P04651, P07434, P08751, P0DN86, P0DN87, P17490, P19794, P27767, P30984, P43021, P45646, P45657, P51500, Q04997, Q1L6U9, Q2Q1P0, Q2Q1P1, Q2Q1P2, Q3HRV3, Q3S2X5, Q6EV78, Q6HA10, Q6NT52, Q6PX77, Q7ZZV4, Q8CB67

Diamond homologs: A1BN60, A1BN61, A6NKQ9, O09108, O13050, O46430, O46482, O46483, O46641, O57340, O73824, O77805, O77835, P01222, P01223, P01224, P01225, P01226, P01227, P01228, P01229, P01230, P01231, P01232, P01235, P04651, P04652, P04837, P07434, P07732, P08751, P0DN86, P0DN87, P10256, P10257, P12656, P12837, P18427, P19794, P25330

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

48 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance37
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

231 predictions. Top by Δscore:

VariantEffectΔscore
19:49054836:CTCA:Cdonor_loss1.0000
19:49054837:TCA:Tdonor_loss1.0000
19:49054838:CA:Cdonor_loss1.0000
19:49054839:A:ACdonor_gain1.0000
19:49054840:C:CCdonor_gain1.0000
19:49054839:AC:Adonor_gain0.9900
19:49054840:CC:Cdonor_gain0.9900
19:49054840:CCATG:Cdonor_gain0.9900
19:49055007:CC:Cacceptor_gain0.9900
19:49055007:CCCTG:Cacceptor_loss0.9900
19:49055008:CC:Cacceptor_gain0.9900
19:49055008:CCT:Cacceptor_loss0.9900
19:49055009:C:Aacceptor_loss0.9900
19:49055009:C:CCacceptor_gain0.9900
19:49055009:C:Tacceptor_gain0.9900
19:49055010:T:Aacceptor_loss0.9900
19:49054614:CG:Cacceptor_gain0.9800
19:49054615:G:Cacceptor_gain0.9800
19:49055005:GCCC:Gacceptor_gain0.9800
19:49055006:CCC:Cacceptor_gain0.9800
19:49055006:CCCC:Cacceptor_gain0.9800
19:49055007:CCC:Cacceptor_gain0.9800
19:49054613:CCGTG:Cacceptor_gain0.9700
19:49054614:C:Tacceptor_gain0.9700
19:49054840:CCA:Cdonor_gain0.9700
19:49054840:CCAT:Cdonor_gain0.9700
19:49055004:AGCCC:Aacceptor_gain0.9700
19:49054601:CGGGT:Cacceptor_gain0.9600
19:49054615:G:GCacceptor_gain0.9600
19:49054617:G:Cacceptor_gain0.9600

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000289437 (19:49055296 C>T), RS1000373517 (19:49058545 C>G), RS1000476557 (19:49058905 A>G), RS1000744674 (19:49057748 A>G,T), RS1000820047 (19:49057873 G>C,T), RS1002420522 (19:49056888 C>T), RS1002492591 (19:49057027 C>A,G,T), RS1002752794 (19:49056170 GC>G), RS1004507022 (19:49055698 C>G), RS1004630905 (19:49057928 T>C,G), RS1004704480 (19:49059063 G>C,T), RS1005066804 (19:49058165 A>T), RS1006600357 (19:49056282 G>A,T), RS1008303229 (19:49055817 C>T), RS1008575791 (19:49058630 G>A)

Disease associations

OMIM: gene MIM:608826 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006979_686Heel bone mineral density3.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0009270heel bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, increases expression2
perfluorooctane sulfonic aciddecreases reaction, increases expression1
seocalcitoldecreases expression1
abrineincreases expression1
perfluorobutanesulfonic aciddecreases reaction, increases expression1
jinfukangaffects cotreatment, increases expression1
Acetaminophenincreases expression1
Cisplatinaffects cotreatment, increases expression1
Estradiolaffects cotreatment, increases expression1
Colforsinincreases expression, decreases reaction1
Valproic Acidincreases methylation1
Aflatoxin B1increases expression1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.